Related Experiment Video

Updated: May 3, 2026

A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells
11:15

A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells

Published on: May 6, 2018

9.9K

Biological effects of cancer-secreted factors on human mesenchymal stem cells

Paula Y P Lam

    Stem Cell Research & Therapy
    |January 25, 2014
    PubMed

    Insights

    Mesenchymal stem cells (MSCs) show dual effects on tumors. Tumor-derived factors, like IL-1β and TGF-β, alter MSC behavior, influencing their potential therapeutic applications.

    Area of Science:

    • Cell Biology
    • Cancer Research
    • Stem Cell Therapy

    Background:

    • Mesenchymal stem cells (MSCs) are explored as gene therapy vectors due to tumor-homing properties.
    • Existing research presents conflicting data on whether MSCs promote or inhibit tumor growth.

    Purpose of the Study:

    • To investigate the cellular interactions between MSCs and tumors.
    • To understand how tumor microenvironments influence MSC behavior and gene expression.

    Main Methods:

    • Utilized conditioned media from various cancer cell lines to treat MSCs.
    • Analyzed changes in MSC phenotype and gene expression in response to tumor-derived factors.

    Main Results:

    • Conditioned media from different cancer cells significantly altered MSC phenotype and gene expression.
    • Tumor-derived interleukin-1 beta (IL-1β) and transforming growth factor-beta (TGF-β) signaling were identified as key modulators of these MSC changes.

    Conclusions:

    • MSC behavior is plastic and can be modulated by the tumor microenvironment.
    • Understanding these interactions is crucial for optimizing MSC-based cancer therapies and clarifying their controversial roles.

    More Related Videos

    Mesenchymal Stem Cell Isolation from Pulp Tissue and Co-Culture with Cancer Cells to Study Their Interactions09:30

    Mesenchymal Stem Cell Isolation from Pulp Tissue and Co-Culture with Cancer Cells to Study Their Interactions

    Published on: January 7, 2019

    9.7K
    Isolation and Functional Assessment of Human Breast Cancer Stem Cells from Cell and Tissue Samples07:03

    Isolation and Functional Assessment of Human Breast Cancer Stem Cells from Cell and Tissue Samples

    Published on: October 2, 2020

    4.5K

    Related Concept Videos

    Mesenchymal Stem Cells01:19

    Mesenchymal Stem Cells

    Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
    4.5K
    Regulation of Hematopoietic Stem Cells01:01

    Regulation of Hematopoietic Stem Cells

    All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
    3.4K
    Cancer Stem Cells and Tumor Maintenance02:40

    Cancer Stem Cells and Tumor Maintenance

    Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
    Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
    4.3K
    The Tumor Microenvironment02:17

    The Tumor Microenvironment

    Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
    6.3K
    Stem Cell Therapy for Tissue Regeneration01:21

    Stem Cell Therapy for Tissue Regeneration

    Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
    Types of Stem Cells used in Stem Cell Therapy
    The two main cell...
    3.8K
    Metastasis02:30

    Metastasis

    Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
    Epithelial-to-Mesenchymal Transition
    The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
    5.4K